CRYO-CELL International CEO Purchases $2,530 in Stock (CCEL)
CRYO-CELL International (NASDAQ:CCEL) CEO Mark L. Portnoy purchased 1,100 shares of CRYO-CELL International stock on the open market in a transaction that occurred on Monday, June 2nd. The stock was purchased at an average cost of $2.30 per share, with a total value of $2,530.00. Following the transaction, the chief executive officer now directly owns 162,574 shares in the company, valued at approximately $373,920. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
CRYO-CELL International (NASDAQ:CCEL) traded down 2.89% during mid-day trading on Wednesday, hitting $2.35. The stock had a trading volume of 6,600 shares. CRYO-CELL International has a one year low of $1.80 and a one year high of $2.81. The stock’s 50-day moving average is $2.42 and its 200-day moving average is $2.12. The company has a market cap of $24.4 million and a price-to-earnings ratio of 142.35.
Cryo-Cell International, Inc (NASDAQ:CCEL) is engaged in cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood stem cells for family use.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.